title: Increased soluble CD4 in serum of rheumatoid arthritis patients is generated by matrix metalloproteinase (MMP)-like proteinases.
abstract: Higher soluble CD4 (sCD4) levels in serum have been detected in patients of infectious and chronic inflammatory diseases. However, how and why sCD4 is produced remains poorly understood. We establish sensitive ELISA and WB assays for sCD4 detection in conditioned medium of in vitro cell culture system and serum of chronic inflammatory patients. Serum samples from patients with systemic lupus erythematosus (SLE) (n = 79), rheumatoid arthritis (RA) (n = 59), ankylosing spondylitis (AS) (n = 25), gout (n = 31), and normal controls (n = 99) were analyzed using ELISA for sCD4 detection. Results from each assay were analyzed by the Kruskal-Wallis test. Dunn's multiple comparison post-test was then applied between groups. We confirm that cells expressing exogenous CD4 produce sCD4 in a constitutive and PMA-induced manner. Importantly, sCD4 production in a heterologous expression system is inhibited by GM6001 and TAPI-0, suggesting receptor shedding by matrix metalloproteinase (MMP)-like proteinases. Moreover, similar findings are recapitulated in human primary CD4(+) T cells. Finally, we show that serum sCD4 levels are increased in patients of chronic inflammatory diseases including RA and SLE, but not in those with gout. Intriguingly, sCD4 levels in RA patients are correlated positively with the disease activities and higher sCD4 levels seem to associate with poor prognosis. Taken together, we conclude that CD4 is shed from cell surface by a MMP-like sheddase and sCD4 level is closely related with the inflammatory condition in certain chronic diseases. Hence, sCD4 might be considered an important parameter for RA disease progression with potential diagnostic importance.
authors.affiliation: Division of Rheumatology, Allergy and Immunology, Chang Gung Memorial Hospital at Keelung, Keelung, Taiwan.
authors.forename: Wen-Yi
authors.initials: WY
authors.lastname: Tseng
authors.forename: Yi-Shu
authors.initials: YS
authors.lastname: Huang
authors.forename: Nien-Yi
authors.initials: NY
authors.lastname: Chiang
authors.forename: Yeh-Pin
authors.initials: YP
authors.lastname: Chou
authors.forename: Yeong-Jian Jan
authors.initials: YJ
authors.lastname: Wu
authors.forename: Shue-Fen
authors.initials: SF
authors.lastname: Luo
authors.forename: Chang-Fu
authors.initials: CF
authors.lastname: Kuo
authors.forename: Ko-Ming
authors.initials: KM
authors.lastname: Lin
authors.forename: Hsi-Hsien
authors.initials: HH
authors.lastname: Lin
mesh_terms: D000818:Animals; D001172:Arthritis, Rheumatoid / Q000175:diagnosis / Q000276:immunology / Q000378:metabolism*; D001327:Autoimmune Diseases / Q000097:blood / Q000276:immunology / Q000378:metabolism; D015704:CD4 Antigens / Q000097:blood / Q000235:genetics / Q000378:metabolism*; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology / Q000378:metabolism; D016466:CHO Cells; D003412:Cricetulus; D006801:Humans; D007249:Inflammation / Q000097:blood / Q000276:immunology / Q000378:metabolism; D020782:Matrix Metalloproteinases / Q000378:metabolism*; D011379:Prognosis; D014162:Transfection
chemical_list: D015704:CD4 Antigens; D020782:Matrix Metalloproteinases